Routine pneumocystis pneumonia prophylaxis in patients treated with rituximab?

Chest

Volumn 144, Issue 1, 2013, Pages 359-360

  Besada, Emilio ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

RITUXIMAB;

HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFECTION RISK; LETTER; LYMPHOCYTE DEPLETION; META ANALYSIS (TOPIC); MORBIDITY; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW (TOPIC);

EID: 84880048687     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.13-0530     Document Type: Letter

References (3)

1. Martin-Garrido I, Carmona EM, Specks U, Limper AH. Pneu mocystis pneumonia in patients treated with rituximab. Chest. 2013; 144 (1): 258-265.
2. Green H, Paul M, Vidal L, Leibovici L. Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIVinfected patients: systematic review and meta-analysis of randomized controlled trials. Mayo Clin Proc. 2007; 82 (9): 1052-1059.
3. Fishman JA. Prevention of infection caused by Pneumocystis carinii in transplant recipients. Clin Infect Dis. 2001; 33 (8): 1397-1405.